GAITHERSBURG, Md., May 5, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- MedImmune, Inc.
(Nasdaq: MEDI) announced today that Wayne T. Hockmeyer, Ph.D., MedImmune's
chairman and founder, has received the University of Maryland's Robert H.
Smith School of Business 2006 Leadership Excellence Award. Presented at a
reception on Thursday, May 4, the award honors a regional business or academic
leader who has significantly impacted his or her industry and demonstrated a
strong commitment to the mid-Atlantic region.
"We are pleased to present the 2006 Leadership Excellence Award to Dr.
Hockmeyer in recognition of his long history of leadership in the community
and continued contributions to our region's growth and development," said
Howard Frank, dean of the Robert H. Smith School of Business. "He exemplifies
the spirit of the Smith Leadership and Excellence Awards, which honor leaders
working to advance business practices and improve their communities."
As MedImmune's chairman, founder, and former chief executive officer, Dr.
Hockmeyer has helped guide the company to its current position as the eighth
largest biotechnology company in the United States. He is also president of
MedImmune Ventures, Inc., the company's wholly owned venture capital
subsidiary that invests in promising early- to late-stage biotechnology
companies. Dr. Hockmeyer's leadership role extends to the local and regional
business community, including his involvement with the Maryland Economic
Development Commission and the Governor's Workforce Investment Board (GWIB).
He also serves as a director of several public and private biotechnology
"We are proud to see this recognition of Dr. Hockmeyer's exceptional
leadership, both as MedImmune's founder and chairman and as a driving force
for innovation and growth in the region's biotechnology industry," said David
M. Mott, MedImmune's president and chief executive officer. "The values upon
which he founded the company in 1988, including high integrity and an
entrepreneurial spirit, continue to provide the framework for our corporate
culture and serve as an inspiration for our emerging leaders."
The 2006 Smith Leadership and Excellence Awards honorees were selected
from nominations submitted by the regional business and academic communities.
Finalists were judged by a panel of business and academic leaders that
included members of the Smith School Board of Visitors, the Dean's Advisory
Council, faculty and staff.
About MedImmune and MedImmune Ventures, Inc.
MedImmune strives to provide better medicines to patients, new medical
options for physicians, rewarding careers to employees, and increased value to
shareholders. Dedicated to advancing science and medicine to help people live
better lives, the company is focused on the areas of infectious diseases,
cancer and inflammatory diseases. With more than 2,200 employees worldwide,
MedImmune is headquartered in Gaithersburg, Maryland.
MedImmune Ventures, Inc. is a wholly owned venture capital subsidiary of
MedImmune, Inc. It was created in 2002 to leverage the company's expertise in
discovering, developing and commercializing biotechnology products, as well as
its financial resources, to transform new ideas in biotechnology into
successful products and companies. MedImmune Ventures invests in early- to
late-stage, public or private biotechnology companies focused on discovering
and developing human therapeutics. It primarily seeks to invest in areas of
strategic interest to MedImmune, including infectious disease, immunology and
For more information, visit the company's website at
SOURCE MedImmune, Inc.
Kate Barrett of MedImmune, Inc., +1-301-398-4320